EIR Zhejiang Guobang Pharmaceutical Sep 2015

Timothy Kapsala FDA$595.00 - Available Now

FDA investigators audited the Zhejiang Guobang Pharmaceutical - Shangyu, China facility and issued inspectional observation (via FDA 483) on 24 Sep 2015.

Product details

  • Category:
  • Inspection end: 24 Sep 2015
  • Location: Shangyu, China
  • FEI: 3008617115
Add To Cart